PsyCom Pro: ADHD treatments may also help executive function deficits
New research from Massachusetts General Hospital found that currently available treatments for ADHD in adults also have positive effects on executive function.
While not included in the official criteria for ADHD, executive function deficits including difficulty maintaining attention and concentration; holding information in working memory; and planning, organizing and executing tasks.
The University of Cincinnati's Jeffrey Strawn, MD, treats patients with ADHD and told PsyCom Pro that executive function deficits sometimes underlie many of the difficulties patients experience.
“These include forgetting important items, disorganization, and difficulty shifting from one topic to another in conversation, and may even relate to impulsivity and risk-taking in some,” said Strawn, professor in the Department of Psychiatry and Behavioral Neuroscience in UC’s College of Medicine and a UC Health child and adolescent psychiatrist.
Featured photo at top courtesy of Unsplash.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.